Wedbush analyst David Nierengarten weighed in in Applied Genetic Technologies Corp. (NASDAQ: AGTC) with shares down 25% after achromatopsia (ACHM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE